secwatch.observer — SEC 8-K summary
======================================

Issuer:     CORCEPT THERAPEUTICS INC (CORT)
CIK:        0001088856
Form:       8-K
Filed at:   2026-05-28T20:04:39+00:00
Accession:  0001628280-26-038793
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Corcept shareholders approve 8M-share increase to 2024 Incentive Award Plan
---------------------------------------------------------------------------

- Stockholders approved amendment to 2024 Incentive Award Plan, adding 8,000,000 authorized shares.
- All eight director nominees elected; vote totals show majority support for each.
- Ernst & Young ratified as independent auditor for fiscal 2026.
- Advisory vote on named executive officer compensation passed with 72.5 million 'for' votes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1088856/000162828026038793/0001628280-26-038793-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1088856/000162828026038793/cort-20260521.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-038793

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer